https://www.avient.com/industries/healthcare/drug-delivery-systems/auto-injectors-and-drug-delivery-pens
Mevopur™ LQ Liquid Color & Additives for Healthcare
https://www.avient.com/industries/healthcare/catheter-materials-medical-tubing/catheters
Colorants for Liquid Silicone Rubber
https://www.avient.com/news/polyone-announces-asset-realignment-brazil
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks; changes in polymer consumption growth rates where the Company conducts business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters, including any developments that would require any increase in the Company’s costs and/or reserves for such contingencies; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the speed and extent of an economic recovery, including the recovery of the housing markets; the financial condition of the Company’s customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; disruptions, uncertainty or volatility in the credit markets that may limit the Company’s access to capital; other factors affecting the Company’s business beyond the Company’s control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation; the Company’s ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen disruptions of service or quality caused by such closings and/or production shifts; the timing of the recognition of the charges that will be incurred; separation and severance amounts and plant exit costs that differ from original estimates; amounts for non-cash charges related to asset write-offs, asset impairments, and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; the Company’s
ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into the Company’s operations, retain the management teams of acquired companies, and retain relationships with customers of acquired companies, including, without limitation, Spartech Corporation; and other factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2013 under Item 1A, “Risk Factors.”
https://www.avient.com/news/polyone-announces-ceo-succession
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/news/polyone-announces-25-increase-quarterly-dividend
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen disruptions of service or quality caused by such closings and/or production shifts; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies and retain relationships with customers of acquired companies including without limitations Spartech Corporation; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/news/where-sustainability-matters-avient-highlight-its-latest-solutions-support-circular-economy-chinaplas-2023
Hiformer™ Liquid Additives for Polyolefins: offer significant reduction of melt fracture and die build-up for polyolefin film applications to improve processing efficiency and save machine start-up time.
https://www.avient.com/industries/consumer/consumer-discretionary/outdoor-recreation/outdoor-adventure-gear
Liquid Color Concentrates and Dosing
https://www.avient.com/sites/default/files/resources/PolyOne%25202016%2520Annual%2520Report%2520Web.pdf
By
laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk.
The following table summarizes our liquidity as of December 31, 2016:
Cash and cash equivalents $ 226.7
Revolving credit availability 386.2
Liquidity $ 612.9
As of December 31, 2016, 83% of the Company’s cash and cash equivalents resided outside the United States.
Expected sources of cash in 2017 include cash from operations and available liquidity under our revolving credit
facility, if needed.
https://www.avient.com/sites/default/files/resources/PolyOne%25202015%2520Annual%2520Report.pdf
By laddering the maturity structure, we avoid concentrations of debt maturities, reducing
liquidity risk.
The following table summarizes our liquidity as of December 31, 2015:
Cash and cash equivalents $279.8
Revolving credit availability 341.9
Liquidity $621.7
As of December 31, 2015, 70% of the Company’s cash and cash equivalents resided outside the
United States.
Expected sources of cash in 2016 include cash from operations and available liquidity under our
revolving credit facility, if needed.
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
Mevopur color and performance concentrates as
well as ready-to-use formulations add value to a
wide range of applications:
MEDICAL DEVICES
• Drug delivery
• Catheters
• Renal care/dialysis
• Surgical instruments
• Dental instruments
• Medical device packaging
• Electronic instruments and accessories
for monitoring
PHARMACEUTICAL PACKAGING
• Vials, ampoules
• Bottles for pills, liquid medicines
• Blister packaging
IN VITRO DIAGNOSTICS (IVD)
• Blood analysis
• IVD devices
• IVD disposables (e.g., pipette tips)
• Point-of-Care
To meet various manufacturing processes,
colorants and functional additives are provided
as concentrates for dilution into the polymer or
as ready-to-use formulations.